+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neonatal digestive implantation of streptococcus group B. Influence of antibiotic therapy



Neonatal digestive implantation of streptococcus group B. Influence of antibiotic therapy



Archives Francaises de Pediatrie 49(5): 415-424



Group B streptococcus (GBS) is an important cause of neonatal infection. Early-onset diseases are due to perinatal contamination. The epidemiology of late-onset infections is poorly known. Maternal colonization may be responsible for some of them. The relationships between neonatal colonization and late disease could be a colonization of the gut. The purpose of this 3 year-prospective study was to analyse the kinetics of gut colonization in neonates and the influence of antibiotherapy. One hundred and nineteen infants less than one month of age were included because of the presence of GBS in their gastric aspirates or GBS infection. Depending on the therapeutic strategy, the infants were separated into 3 groups: 1) amoxicillin plus aminoside greater than or equal to 10 days because of neonatal infection (28 infants), 2) same combination less than or equal to 5 days because a GBS infection was suspected but not confirmed (17 infants), 3) no antibiotics (77 infants). Fecal flora was regularly analysed by differential count. Antibiotics caused rapid disappearance of GBS from the gut. However, the same strain reappeared after stopping the antibiotics at a rate of 13.5%. Without antibiotics, GBS was implanted in 33% of cases. This difference of implantation rate is statistically significant (p less than 0.05). No GBS infection was observed in any infant after a follow-up examination of 6 months to 2 years. Among the clinical and bacteriological factors studied, adhesion only was correlated with the GBS implantation. These results allow to discuss therapeutic abstention in colonized infants without any signs of infection.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040780737

Download citation: RISBibTeXText

PMID: 1530437


Related references

Significant decrease in early-onset neonatal sepsis caused by group B Streptococcus and other penicillin-susceptible organisms in an era of group B Streptococcus intrapartum antibiotic prophylaxis. American Journal of Obstetrics & Gynecology 184(1): S84, 2001

Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis. Swiss Medical Weekly 143: W13778, 2013

No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. American Journal of Obstetrics and Gynecology 192(4): 1167-1171, 2005

Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains. Applied Microbiology and Biotechnology 98(13): 6051-6060, 2014

Appropriateness of Intrapartum Antibiotic Prophylaxis to Prevent Neonatal Group B Streptococcus Disease. Plos one 11(11): E0166179, 2016

Descriptive study of intrapartum antibiotic prophylaxis of neonatal infection by group B Streptococcus in Txagorritxu. Revista de Enfermeria 35(2): 55-58, 2012

Group B streptococcus neonatal infection in an intensive care unit in Brazil: high fatality and missed opportunities for antibiotic prophylaxis. Brazilian Journal of Infectious Diseases 19(1): 98-99, 2015

Influence of Intrapartum Antibiotic Prophylaxis for Group B Streptococcus on Gut Microbiota in the First Month of Life. Journal of Pediatric Gastroenterology and Nutrition 62(2): 304-308, 2016

Influence of prostaglandin D2 on hemodynamic effects of group B streptococcus in neonatal lambs. Developmental Pharmacology and Therapeutics 9(4): 260-265, 1986

An evaluation of a rapid real time polymerase chain reaction assay for detection of group B streptococcus as part of a neonatal group B streptococcus prevention strategy. Journal of Obstetrics and Gynaecology Canada 30(9): 770-775, 2008

Therapy of neonatal infection caused by group B beta-hemolytic Streptococcus. La Pediatria Medica e Chirurgica 17(4): 305-306, 1995

Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. Pediatric Infectious Disease Journal 18(6): 524-528, 1999

Neonatal Streptococcus group B sepsis: problems of early diagnosis, therapy and prevention. Helvetica Paediatrica Acta 39(5-6): 419-438, 1984

Asymptomatic carriage of group A Streptococcus following beta lactam antibiotic therapy A role for bacterial internalization. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 712, 1999

Acute rheumatic fever and group A Streptococcus tonsillitis Current problems and antibiotic therapy aspects. Antibiotiki i Khimioterapiya 45(4): 22-27, 2000